158 related articles for article (PubMed ID: 37728026)
21. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.
Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H
Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195
[TBL] [Abstract][Full Text] [Related]
22. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.
Neilan TG; Coelho-Filho OR; Danik SB; Shah RV; Dodson JA; Verdini DJ; Tokuda M; Daly CA; Tedrow UB; Stevenson WG; Jerosch-Herold M; Ghoshhajra BB; Kwong RY
JACC Cardiovasc Imaging; 2013 Sep; 6(9):944-54. PubMed ID: 23932642
[TBL] [Abstract][Full Text] [Related]
23. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
[TBL] [Abstract][Full Text] [Related]
24. The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study.
Li Y; Xian H; Xu Y; Li W; Guo J; Wan K; Wang J; Xu Z; Zhang Q; Han Y; Sun J; Chen Y
Cardiovasc Diabetol; 2024 Feb; 23(1):48. PubMed ID: 38302987
[TBL] [Abstract][Full Text] [Related]
25. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
[TBL] [Abstract][Full Text] [Related]
26. Long term prognostic importance of late gadolinium enhancement in first-presentation non-ischaemic dilated cardiomyopathy.
Sree Raman K; Nucifora G; Leong DP; Marx C; Shah R; Woodman RJ; Molaee P; Shirazi MG; McGavigan AD; De Pasquale CG; Selvanayagam JB
Int J Cardiol; 2019 Apr; 280():124-129. PubMed ID: 30679073
[TBL] [Abstract][Full Text] [Related]
27. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
[TBL] [Abstract][Full Text] [Related]
28. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
[TBL] [Abstract][Full Text] [Related]
29. Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies.
Zhang X; Yang S; Hao S; Li J; Qiu M; Chen H; Huang Y
Eur Radiol; 2024 Mar; 34(3):1854-1862. PubMed ID: 37658896
[TBL] [Abstract][Full Text] [Related]
30. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
[TBL] [Abstract][Full Text] [Related]
31. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
[TBL] [Abstract][Full Text] [Related]
32. Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy.
Nabeta T; Ishii S; Ikeda Y; Maemura K; Oki T; Yazaki M; Fujita T; Naruke T; Inomata T; Ako J
ESC Heart Fail; 2021 Feb; 8(1):615-624. PubMed ID: 33270357
[TBL] [Abstract][Full Text] [Related]
33. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
34. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
Mordi I; Bezerra H; Carrick D; Tzemos N
JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
[TBL] [Abstract][Full Text] [Related]
35. Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance.
Slivnick JA; Zareba KM; Truong VT; Liu E; Barnes A; Mazur W; Binkley P
PLoS One; 2022; 17(11):e0264454. PubMed ID: 36399465
[TBL] [Abstract][Full Text] [Related]
36. Can left ventricular entropy by cardiac magnetic resonance late gadolinium enhancement be a prognostic predictor in patients with left ventricular non-compaction?
Ma YT; Wang LJ; Zhao XY; Zheng Y; Sha LH; Zhao XX
Diagn Interv Radiol; 2023 Sep; 29(5):682-690. PubMed ID: 36995015
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
[TBL] [Abstract][Full Text] [Related]
38. Electrocardiogram and CMR to differentiate tachycardia-induced cardiomyopathy from dilated cardiomyopathy in patients admitted for heart failure.
Vera A; Cecconi A; Martínez-Vives P; Olivera MJ; Hernández S; López-Melgar B; Rojas-González A; Díez-Villanueva P; Salamanca J; Tejelo J; Caballero P; Jiménez-Borreguero LJ; Alfonso F
Heart Vessels; 2022 Nov; 37(11):1850-1858. PubMed ID: 35657427
[TBL] [Abstract][Full Text] [Related]
39. The primary cardiomyopathy of systemic sclerosis on cardiovascular magnetic resonance imaging.
Chhikara S; Kanda A; Ogugua FM; Rouf R; Nouraee C; Bawaskar P; Molitor JA; Shenoy C
Eur Heart J Cardiovasc Imaging; 2023 Nov; 24(12):1661-1671. PubMed ID: 37364296
[TBL] [Abstract][Full Text] [Related]
40. Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial.
Foley JRJ; Swoboda PP; Fent GJ; Garg P; McDiarmid AK; Ripley DP; Erhayiem B; Musa TA; Dobson LE; Plein S; Witte KK; Greenwood JP
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):816-823. PubMed ID: 29029139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
